MedTrace Logo

Polish Validation 4AT Tool

NCT04563858 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 444

Last updated 2024-02-06

No results posted yet for this study

Summary

Delirium is a phenomenon which affects patients with various disorders and representing various age groups. Screening instruments make it possible to diagnose the condition at an early stage and to prevent its development. The aim of the study is to examine the reliability and validity of the Polish version of the 4AT (Pol4-AT) in patients after cardiac surgery.

Procedure of validation:

After obtaining the author's consent, the original English version of the 4AT was separately translated by 3 centres working on the validation of the Pol4-AT (University of Rzeszów, Poland; University Hospital in England; Karolinska University, Sweden). Then, three translations were compared, to be approved by the project supervisor (Karolinska University). Any doubts arising during the comparison were consulted with the English translator. As a result, one coherent version was accepted and translated back into English. The questionnaire was distributed in a convenient sample of 20 patients to examine the validity of the face. Vague words and statements were changed, and the final version translated into Polish was created. The Pol4-AT was tested for internal consistency and reliability.

Conditions

  • Delirium, Postoperative
  • Surgical Procedure

Interventions

DIAGNOSTIC_TEST

Validation

Assessment of Polish version of the 4AT

Sponsors & Collaborators

  • University of Rzeszow

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Andrzej Frycz Modrzewski Krakow University

    lead OTHER

Principal Investigators

  • Sabina Krupa, PhD · Medical College of Rzeszow University Institute of Health Sciences

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-22
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04563858 on ClinicalTrials.gov